Disclosed are novel NO-donating compounds, designed such that when NO is released from the compound a residue which is a naturally occurring metabolite is formed, and thus a development of tolerance to the compounds upon repetitive administration is prevented or decreased. Also disclosed are methods of preparing such NO-donating compounds, pharmaceutical compositions and medical devices containing such compounds and methods utilizing such compounds in the treatment of various medical conditions.

 
Web www.patentalert.com

< Ligand for G-protein coupled receptor FPRL2 and uses thereof

> Methods and systems for electrical and/or drug stimulation as a therapy for erectile dysfunction

> Method for detecting activated CD3+ T-cells

~ 00540